Your browser doesn't support javascript.
loading
Chemoproteomics-Enabled Identification of 4-Oxo-ß-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9.
Carvalho, Luís A R; Ross, Breyan; Fehr, Lorenz; Bolgi, Oguz; Wöhrle, Svenja; Lum, Kenneth M; Podlesainski, David; Vieira, Andreia C; Kiefersauer, Reiner; Félix, Rita; Rodrigues, Tiago; Lucas, Susana D; Groß, Olaf; Geiss-Friedlander, Ruth; Cravatt, Benjamin F; Huber, Robert; Kaiser, Markus; Moreira, Rui.
Afiliación
  • Carvalho LAR; Department of Pharmaceutical Sciences and Medicines, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Ross B; Department of Chemistry, The Scripps Research Institute, La Jolla, California, 92037, USA.
  • Fehr L; Max Planck Institut für Biochemie, 82152, PlaneggMartinsried, Germany.
  • Bolgi O; Proteros Biostructures GmbH, 82152, PlaneggMartinsried, Germany.
  • Wöhrle S; Fakultät für Biologie, Zentrum für Medizinische Biotechnologie, Universität Duisburg-Essen, 45117, Essen, Germany.
  • Lum KM; Center of Biochemistry and Molecular Cell Research, Albert-Ludwigs-Universität, 79104, Freiburg, Germany.
  • Podlesainski D; Institut für Neuropathologie, Universitätsklinikum Freiburg, 79106, Freiburg, Germany.
  • Vieira AC; Department of Chemistry, The Scripps Research Institute, La Jolla, California, 92037, USA.
  • Kiefersauer R; Fakultät für Biologie, Zentrum für Medizinische Biotechnologie, Universität Duisburg-Essen, 45117, Essen, Germany.
  • Félix R; Department of Pharmaceutical Sciences and Medicines, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Rodrigues T; Proteros Biostructures GmbH, 82152, PlaneggMartinsried, Germany.
  • Lucas SD; Department of Pharmaceutical Sciences and Medicines, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Groß O; Department of Pharmaceutical Sciences and Medicines, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Geiss-Friedlander R; Department of Pharmaceutical Sciences and Medicines, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Cravatt BF; Institut für Neuropathologie, Universitätsklinikum Freiburg, 79106, Freiburg, Germany.
  • Huber R; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.
  • Kaiser M; Center of Biochemistry and Molecular Cell Research, Albert-Ludwigs-Universität, 79104, Freiburg, Germany.
  • Moreira R; Department of Chemistry, The Scripps Research Institute, La Jolla, California, 92037, USA.
Angew Chem Int Ed Engl ; 61(47): e202210498, 2022 11 21.
Article en En | MEDLINE | ID: mdl-36089535
ABSTRACT
Dipeptidyl peptidases 8 and 9 (DPP8/9) have gathered interest as drug targets due to their important roles in biological processes like immunity and tumorigenesis. Elucidation of their distinct individual functions remains an ongoing task and could benefit from the availability of novel, chemically diverse and selective chemical tools. Here, we report the activity-based protein profiling (ABPP)-mediated discovery of 4-oxo-ß-lactams as potent, non-substrate-like nanomolar DPP8/9 inhibitors. X-ray crystallographic structures revealed different ligand binding modes for DPP8 and DPP9, including an unprecedented targeting of an extended S2' (eS2') subsite in DPP8. Biological assays confirmed inhibition at both target and cellular levels. Altogether, our integrated chemical proteomics and structure-guided small molecule design approach led to novel DPP8/9 inhibitors with alternative molecular inhibition mechanisms, delivering the highest selectivity index reported to date.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dipeptidasas Tipo de estudio: Diagnostic_studies Idioma: En Revista: Angew Chem Int Ed Engl Año: 2022 Tipo del documento: Article País de afiliación: Portugal

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dipeptidasas Tipo de estudio: Diagnostic_studies Idioma: En Revista: Angew Chem Int Ed Engl Año: 2022 Tipo del documento: Article País de afiliación: Portugal